Arrivent Biopharma logo

Arrivent Biopharma Share Price Today

(NASDAQ: AVBP)

Arrivent Biopharma share price is $18.14 & ₹1,550.34 as on 18 Apr 2025, 2.30 'hrs' IST

$18.14

0.24

(1.34%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Arrivent Biopharma share price in Dollar and Rupees. Guide to invest in Arrivent Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Arrivent Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Arrivent Biopharma share price movements

  • Today's Low: $17.70
    Today's High: $18.38

    Day's Volatility :3.7%

  • 52 Weeks Low: $14.35
    52 Weeks High: $36.37

    52 Weeks Volatility :60.54%

Arrivent Biopharma (AVBP) Returns

PeriodArrivent Biopharma, Inc.Index (Russel 2000)
3 Months
-28.33%
0.0%
6 Months
-36.82%
0.0%
1 Year
17.03%
0.0%
3 Years
-9.3%
-12.9%

Arrivent Biopharma (AVBP) Key Statistics

in dollars & INR

Previous Close
$17.9
Open
$17.78
Today's High
$18.3792
Today's Low
$17.7
Market Capitalization
$617.1M
Today's Volume
$179.6K
52 Week High
$36.37
52 Week Low
$14.35
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-2.56
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-39.36%

How to invest in Arrivent Biopharma Stock (AVBP) from India?

It is very easy for Indian residents to invest directly in Arrivent Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arrivent Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arrivent Biopharma or AVBP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arrivent Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arrivent Biopharma shares which would translate to 0.047 fractional shares of Arrivent Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Arrivent Biopharma, in just a few clicks!

Returns in Arrivent Biopharma (AVBP) for Indian investors in Rupees

The Arrivent Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Arrivent Biopharma investment value today

Current value as on today

₹1,19,373

Returns

₹19,373

(+19.37%)

Returns from Arrivent Biopharma Stock

₹17,032 (+17.03%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Arrivent Biopharma (AVBP)

0%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Arrivent Biopharma Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Arrivent Biopharma

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Arrivent Biopharma(by analysts ranked 0 to 5 stars)

Analyst Forecast on Arrivent Biopharma Stock (AVBP)

What analysts predicted

Upside of 116.57%

Target:

$39.29

Current:

$18.14

Insights on Arrivent Biopharma Stock (Ticker Symbol: AVBP)

  • Price Movement

    In the last 6 months, AVBP stock has moved down by -38.6%
  • AVBP vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 60.6%

Arrivent Biopharma Technicals Summary

Sell

Neutral

Buy

Arrivent Biopharma is currently in a neutral trading position according to technical analysis indicators.

Arrivent Biopharma (AVBP) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Arrivent Biopharma, Inc. logo
-8.39%
-36.82%
17.03%
-9.3%
-9.3%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Arrivent Biopharma

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company's lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-helix compressing (PACC) mutations, and classical EGFRm NSCLC patients. It is also developing ARR-217, an antibody drug conjugate (ADC) for the treatment of gastrointestinal cancers; and ARR-002 for solid tumors. The company has strategic collaborations with Aarvik Therapeutics Inc., Shanghai Allist Pharmaceuticals Co., Ltd., Beijing InnoCare Pharma Tech Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and Lepu Biopharma Co. Ltd. ArriVent BioPharma, Inc. was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Organization
Arrivent Biopharma
Employees
52
CEO
Dr. Zhengbin Yao Ph.D.
Industry
Miscellaneous

Management People of Arrivent Biopharma

NameTitle
Dr. Zhengbin Yao Ph.D.
Co-Founder, Chairman, President & CEO
Dr. Stuart Lutzker M.D., Ph.D.
Co-Founder, President of Research & Development and Director
Ms. Robin LaChapelle M.A.
Co-Founder & COO
Mr. Winston Kung M.B.A.
CFO & Treasurer
Ms. Yang Wang Ph.D.
Chief Technology Officer
Mr. James Paul Kastenmayer J.D., Ph.D.
General Counsel & Secretary
Ms. Meghna Chowdary
Senior Vice President of Commercial Strategy

Important FAQs about investing in AVBP Stock from India :

What is Arrivent Biopharma share price today?

Arrivent Biopharma share price today stands at $18.14, Open: $17.78 ; Previous Close: $17.90 ; High: $18.38 ; Low: $17.70 ; 52 Week High: $36.37 ; 52 Week Low: $14.35.

The stock opens at $17.78, after a previous close of $17.90. The stock reached a daily high of $18.38 and a low of $17.70, with a 52-week high of $36.37 and a 52-week low of $14.35.

Can Indians buy Arrivent Biopharma shares?

Yes, Indians can invest in the Arrivent Biopharma (AVBP) from India.

With INDmoney, you can buy Arrivent Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Arrivent Biopharma at zero transaction cost.

How can I buy Arrivent Biopharma shares from India?

It is very easy to buy Arrivent Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arrivent Biopharma (AVBP) be purchased?

Yes, you can buy fractional shares of Arrivent Biopharma with INDmoney app.

What are the documents required to start investing in Arrivent Biopharma stocks?

To start investing in Arrivent Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Arrivent Biopharma Stock (AVBP)?

Today’s highest price of Arrivent Biopharma (AVBP) is $18.38.

Today’s lowest price of Arrivent Biopharma (AVBP) is $17.70.

What is today's market capitalisation of Arrivent Biopharma?

Today's market capitalisation of Arrivent Biopharma AVBP is 617.1M

What is the 52 Week High and Low Range of Arrivent Biopharma Stock (AVBP)?

  • 52 Week High

    $36.37

  • 52 Week Low

    $14.35

What are the historical returns of Arrivent Biopharma (AVBP)?

  • 1 Month Returns

    -8.39%

  • 3 Months Returns

    -36.82%

  • 1 Year Returns

    17.03%

  • 5 Years Returns

    -9.3%

Who is the Chief Executive Officer (CEO) of Arrivent Biopharma ?

Dr. Zhengbin Yao Ph.D. is the current Chief Executive Officer (CEO) of Arrivent Biopharma.